Better Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$21.2M

126 transactions

Summary

Better Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $14.4MSales: $5.4M18 insiders

Date	Insider	Type	Value
2023-07-27	PERRY DAVID P(Executive Chairman)	Buy	$900K
2023-07-27	Parker Geoffrey M.	Buy	$500K
2024-01-09	PERRY DAVID P(Executive Chairman)	A	$250K
2023-07-27	Armanino Andrew J.	Buy	$200K
2024-02-09	Joint reporting: PERRY DAVID P; David P. Perry 2015 Trust	A	$160K
2023-07-27	KARBE FRANK(Chief Executive Officer)	Buy	$100K
2023-07-27	Berman Mark A.(Chief Medical Officer)	Buy	$40K
2023-07-27	Granger Elder	Buy	$25K
2023-12-18	Berman Mark A.(Chief Medical Officer)	A	$0
2023-12-18	KARBE FRANK(Chief Executive Officer)	A	$0
2023-12-18	Granger Elder	A	$0
2023-12-18	Miller Leslie A.(Principal Accounting Officer)	A	$0
2023-12-18	Armanino Andrew J.	A	$0
2023-12-18	Parker Geoffrey M.	A	$0
2023-12-18	Wynholds Kristin(Chief Product Officer)	A	$0
2023-12-18	LAVIZZO-MOUREY RISA J	A	$0
2023-12-18	Carmona Richard H	A	$0
2023-12-18	PERRY DAVID P(Executive Chairman)	A	$0
2023-06-07	PERRY DAVID P(Executive Chairman)	A	$0
2023-06-07	Parker Geoffrey M.	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Better Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope